cyclooctanamine

ID: ALA1170791

Cas Number: 5452-37-9

PubChem CID: 2903

Product Number: C471292, Order Now?

Max Phase: Preclinical

Molecular Formula: C8H17N

Molecular Weight: 127.23

Molecule Type: Small molecule

In stock!

Associated Items:

Names and Identifiers

Synonyms: Cyclooctanamine | Cyclooctanamine|Cyclooctylamine|5452-37-9|Aminocyclooctane|MFCD00001748|HE0JPO6GS5|NSC-18965|cyclooctyl amine|NSC20985|EINECS 226-694-7|NSC 18965|Cyclooctylamine, 97%|Cyclooctylamine, 97+%|UNII-HE0JPO6GS5|SCHEMBL130985|CHEMBL1170791|DTXSID9063900|HSOHBWMXECKEKV-UHFFFAOYSA-|SKF-23880A|AMY14314|NSC18965|STR02206|BDBM50482322|AKOS000119421|SY057104|Cyclooctylamine, purum, >=98.0% (GC)|C1223|CS-0155298|FT-0624244|NS00033113|EN300-20435|D89372|A936620|Q5768893|F8889-3603|Z104478188|Show More

Canonical SMILES:  NC1CCCCCCC1

Standard InChI:  InChI=1S/C8H17N/c9-8-6-4-2-1-3-5-7-8/h8H,1-7,9H2

Standard InChI Key:  HSOHBWMXECKEKV-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

  9  9  0  0  0  0  0  0  0  0999 V2000
    4.4542    3.1542    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.2792    3.1542    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.8637    2.5738    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.8637    1.7488    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.2792    1.1643    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.4542    1.1643    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.8697    1.7488    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.8697    2.5738    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.6253    2.8909    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  1  1  0
  3  9  1  0
M  END

Alternative Forms

  1. Parent:

    ALA1170791

    Cyclooctylamine

Associated Targets(non-human)

M Matrix protein 2 (436 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Biocomponents

Calculated Properties

Molecular Weight: 127.23Molecular Weight (Monoisotopic): 127.1361AlogP: 2.06#Rotatable Bonds:
Polar Surface Area: 26.02Molecular Species: BASEHBA: 1HBD: 1
#RO5 Violations: HBA (Lipinski): 1HBD (Lipinski): 2#RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 10.45CX LogP: 2.06CX LogD: -0.68
Aromatic Rings: Heavy Atoms: 9QED Weighted: 0.53Np Likeness Score: 0.01

References

1. Eleftheratos S, Spearpoint P, Ortore G, Kolocouris A, Martinelli A, Martin S, Hay A..  (2010)  Interaction of aminoadamantane derivatives with the influenza A virus M2 channel-docking using a pore blocking model.,  20  (14): [PMID:20570509] [10.1016/j.bmcl.2010.05.049]

Source